Pilot
Privexa Trace
Reviewer-gated evidence workflows with lineage and visible limitations.
Evidence workflow software for cohort construction, manual benchmark comparison, dataset fit review, and submission-oriented traceability.
What it supports
Practical capabilities for protected, reviewable AI workflows.
- Build and review evidence packages with lineage visible throughout.
- Support synthetic control arm and manual benchmark workflows.
- Capture dataset fit, reviewer notes, limitations, and sign-off.
- Connect healthcare and diagnostic adoption pathways through Translyx.
Who it is for
Common audiences and operating environments.
HealthcareDiagnosticsPharmaCROsResearch teams
Workflow fit
Use cases and governance controls
Use cases
- Reviewer-gated evidence workflow preparation.
- Manual benchmark and synthetic control arm support.
- Dataset-fit review for clinical or diagnostic evidence workflows.
- Submission-oriented packages with visible assumptions and limitations.
Safeguards
- Reviewer sign-off remains central to the workflow.
- Limitations, exclusions, and dataset lineage are made visible.
- Clinical adoption in New Zealand and Oceania is positioned through Translyx Limited.
Responsible use
- Does not replace clinical trials or regulatory evidence requirements.
- No regulatory approval or diagnostic approval is implied.
- Regulatory status and intended use vary by product and jurisdiction.
Clinical technology through Translyx
For healthcare, diagnostics, digital pathology partnerships, and clinical product introduction in New Zealand and Oceania, Privexa-built software is clinically positioned through Translyx Limited.
Build safer AI workflows with Privexa
Discuss product fit, deployment requirements, and governance needs with the Privexa team.